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Introduction 
Extramural venous invasion (EMVI) is widely regarded as an adverse prognostic 
feature in rectal cancer. Whist the effect of venous invasion has been studied for 
more than seven decades, Talbot’s study from St. Mark’s hospital in 1980 was  the 
first to  specify the importance of extramural versus intramural venous invasion; and 
show that it was only invasion of tumour into the extramural veins that had a 
prognostic effect (1). However the current literature is somewhat confusing, which is 
most likely due to heterogeneity of definitions. We discuss some of the available 
evidence and offer guidance on the optimal criteria for both histopathological and 
radiological detection of EMVI within the context of modern management of rectal 
cancer. 
 
Prevalence 
The true prevalence of histopathological  EMVI (pEMVI) in rectal cancer is difficult to 
know and hinges on the rigour of macroscopic and microscopic pathological 
evaluation, and whether ancillary techniques have been used. Reported detection 
rates have been inconsistent and the incidence ranges from (9-61%) (1-12). Some 
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series have shown selection bias towards advanced cases which may affect the true 
prevalence and result in a high EMVI detection rate (13), whilst others do not 
differentiate between rectal and colonic tumours. A more recent challenge has been 
that the increasing use of pre-operative radiotherapy has led to an inherent false-
negative rate, resulting in under-reporting of venous invasion due to obliteration of 
normal venous architecture when involved veins are destroyed beyond recognition 
(14).  
 
Histopathology-based detection 
Optimal Macroscopic examination   
Rectal cancer resection specimens must be appropriately opened, pinned out and 
fixed in formalin solution for at least 48 hours before dissection. Once adequately 
fixed, the specimen should be cross-sectionally sliced transversely at a thickness of 
three to four millimetres; these thin slices allow identification of the depth of tumour 
invasion and status of the circumferential resection margin. In addition, serpiginous 
outgrowths of tumour extending beyond and at right angles to the muscularis propria 
may be visible and likely represent a focus of EMVI (figure 1). Areas for microscopic 
examination are then selected with at least four sections of tumour taken targeting 
areas of greatest interest. Evidence suggests that sections taken perpendicular to 
the tumour at the area of maximal invasion are most likely to identify EMVI (16). As 
many rectal tumours will have undergone neoadjuvant radiotherapy, it may be 
difficult to identify areas of residual tumour; in this instance a greater number of 
blocks maybe required concentrating on areas of fibrosis in the region of the 
irradiated tumour. 
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Optimal Microscopic examination 
The microscopic identification of EMVI relies upon of the identification of tumour cells 
within an endothelial or smooth muscle-lined space containing red blood cells 
outside the muscularis propria of the bowel wall as defined in the UK Royal College 
of Pathologists (RCPath) guidelines for reporting colorectal cancer (17). Due to the 
difficulties associated with tissue sectioning and architectural distortion by tumour or 
fibrosis, vascular spaces may become difficult to identify on routine haematoxylin 
and eosin (H & E) staining (figure 2).  As a result the rate of EMVI with H & E 
staining has been documented to be as low as 8% (18), however, the RCPath 
guidelines suggest that EMVI should be detected in at least 25% of cases of 
colorectal cancer. There is no guidance as to the expected rate in rectal cancers 
alone or those treated with neo-adjuvant radiotherapy however 25% may still be an 
underestimate for the true prevalence of EMVI using optimal sampling technique. 
There is poor agreement, even between specialist gastrointestinal histopathologists, 
when identifying vascular invasion using H & E (19). In situations where uncertainty 
or disagreement exists as to the nature of subserosal tumour deposits, the RCPath 
guidelines recommend that deeper sections through the tissue block should be 
performed to attempt to clarify the nature of a lesion; alternatively special 
histochemical and immunohistochemical stains can be invaluable tools.   
 
Special Stains: histochemical staining 
The elastic lamina within medium-to-large vessels provides a landmark, which can 
be highlighted by special stains such as orcien and elastin Van Gieson (EVG); the 
application of these stains has been shown to increase the detection of EMVI from 
19.6 to 58% (20). Staining for the elastic lamina also improves agreement between 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
pathologists from poor to fair (19). The only significant drawback of these methods is 
that in selected cases interpretation maybe hampered by background staining 
although this is rare.  
 
Special stains: immunohistochemistry 
Immunohistochemical stains using antibodies directed towards endothelial (CD31 
and CD34) or smooth muscle (smooth muscle actin) antigens within vessel walls 
also increase the sensitivity of histopathology-detected EMVI.  The potential 
advantage of these methods is an increased specificity over histochemical staining, 
although the endothelium may become lost or obscured when a tumour embolus 
occupies a vessel. 
 
Kingston et al examined the rate of detection when using H & E, EVG and 
immunohistochemistry for CD31 and CD34 in fifty cases of colorectal cancer in 
which vascular invasion had previously not been identified; with the use of special 
stains they identified vascular invasion in 48% of cases (21). Although this study did 
not differentiate between intramural and extramural vascular invasion, it showed that 
EVG was the most sensitive method, however, in a minority of cases 
immunohistochemical staining was still required. An example of these histochemical 
and immunohistochemical stains in practice is shown in figure 3a-e.   
 
MRI-based detection 
Optimal Technique 
High-resolution MRI is accurate in detecting EMVI (mrEMVI) both before and after 
pre-operative therapy. Accurate detection is underpinned by strict adherence to 
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technique and image acquisition as well as a three-dimensional understanding of the 
vascular anatomy surrounding the rectum. Failure of the latter can confuse venous 
invasion with nodal disease. Most scanners will provide adequate 3mm slices, 
however optimal technique involves ensuring appropriate field of view (FOV) – 
16x16cm; to obtain high-resolution images. Incorrect FOV also results in loss of 
voxel size and ultimately resolution. Furthermore, the field alignment must be 
perpendicular to the long axis of the rectum or vessels can be missed. 
 
Characteristic radiological features of EMVI 
Veins around the rectum are recognised on T2-weighted images as serpiginous or 
tortuous linear structures which appear black due to the signal void of blood. The 
larger, ‘named’ vessels such as the superior and middle rectal veins appear with 
anatomical consistency, which helps in confident identification Detection of mrEMVi 
relies on the observation of intermediate tumour signal disrupting the normal 
configuration of the vessel resulting in irregular expansion of the vein, loss of the 
signal void and intermediate signal intensity which may or may not be contiguous 
with the main tumour in the rectal wall (22). Smaller venules can be seen perforating 
the normal outer rectal wall and produce a low to intermediate signal intensity in 
tubular structures on T2-weighted images - these are normal vessels and should not 
be confused with mrEMVI (23). Venous invasion into these smaller venules can be 
seen recognised by their expansion and irregularity adjacent to the tumour due to 
contiguous tumour extension (Figures 4a-c).  
Early studies showing correlation with histopathology 
The first study to demonstrate the accuracy of MRI in identifying the EMVI as a 
prognostic feature of rectal cancer involved 98 patients with biopsy-proven rectal 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
cancer (24). The prognostic significance of MRI-detected EMVI (mrEMVI) has further 
been documented in a study by Smith et al (25). They offered a scoring system 
based on previous experience which identified particular morphological and signal 
characteristics. Recurrence free survival at three years was compared between MRI 
and histopathology-detected EMVI and was reported as 35% and 34%, respectively. 
Recurrence-free survival when EMVI was not present was 73.8% and 74.1% 
respectively. A further study using similar grading criteria reported mrEMVI in 42% of 
patients undergoing primary surgery for rectal cancer. mrEMVI score of 3-4 had 
100% sensitivity and 89% specificity in identifying EMVI involving veins greater than 
three millimetre diameter (26).  
 
The potential of mrEMVI as an imaging biomarker 
The prognostic effect of traditional adverse features has not been prospectively 
validated in patients who have undergone pre-operative therapy. Perhaps those 
features which we previously understood as having a significant bearing on survival 
outcomes may not be as important following CRT providing optimal surgery has 
taken place – such as nodal disease (27).  
 
MRI is accurate in identifying EMVI following chemoradiation providing the same 
diagnostic standard is used (28, 29). Indeed, a comparison between the outcomes of 
patients with MRI-detected EMVI and pathology-detected EMVI showed that not only 
is it associated with poor disease-free survival when either technique is used, but 
MRI identified more cases of EMVI than pathology following CRT (30). Further, a 
recent study involving stage II and stage III patients who had undergone pre-
operative long-course chemoradiotherapy showed that evidence of EMVI led to 
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significantly worse disease recurrence and in fact, stage II tumours with EMVI had 
similar outcomes as stage III tumours (31). mrEMVI has also been shown to be a 
potential imaging biomarker following neoadjuvant chemoradiotherapy. EMVI can be 
graded following CRT using a regression grading score based on the degree of 
radiological evidence of fibrosis shown and this can be linked to survival outcomes. 
Patients that demonstrated fibrosis of more than 50% in EMVI had a 3-year DFS of 
87.9%. Where there was less than 50% fibrosis DFS was 45.8%. Fibrosis of less 
than 50% had a hazard ratio of 5.75 for disease recurrence (32). 
 
Conclusion 
There is now substantial evidence suggesting that EMVI is an adverse prognostic 
feature in rectal cancer, including in cases treated with neoadjuvant therapy. Whilst 
special stains undoubtedly increases the reporting rates, H&E staining unfortunately 
remains the gold standard for most institutions. The use of special stains will improve 
detection rates particularly following CRT and must surely now be considered as 
routine in addition to meticulous technique.  
Furthermore, MRI can identify EMVI at the same rate as histopathology and predicts 
the same outcome. Using the radiological criteria described above will allow for more 
consistent reporting of EMVI in the pre-operative setting. Multidisciplinary teams are 
urged to regularly audit the reporting rates of EMVI using both MRI and 
histopathology to ensure good concordance.  
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Figure 1 Gross pathology specimen showing tumour with EMVI. Intravascular tumour 
deposits can be seen as serpigenous extensions of tumour projecting from and at 
right angles to the muscularis propria (see arrows). 
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Figure 2 – Micrograph showing venous invasion as a linear extension of tumour 
projecting beyond the muscularis propria (see arrow). The vessel wall is largely 
destroyed by tumour and an appreciation of the characteristic architecture is required 
to accurately recognise this phenomenon. 
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Figure 3– Extramural venous invasion demonstrated on H&E staining (A) and 
confirmed using elastin Van Gieson (B), and antibodies against smooth muscle actin 
(C), CD34 (D) and CD31 (E). The position of tumour within the vessel is highlighted 
by an arrow. 
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Figure 4a – MRI showing tumour invasion into superior rectal vein. Dashed arrow 
indicates tumour extension. Solid arrow shows signal void in vessel which is 
surrounded by tumour 
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Figure 4b – MRI showing tumour extending into middle rectal vein. The dashed 
arrow shows signal void (black) shown in middle rectal vein; the solid arrow shows 
tumour extension beyond the muscularis 
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Figure 4c – MRI showing tumour in the inferior rectal vein. There is signal void which 
could be followed on sequential images confirming this was the inferior rectal vein. 
 
